Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes

BACKGROUND: Multiple phase I-II clinical trials have reported on the efficacy and safety of prostate stereotactic body radiotherapy (SBRT) for the treatment of prostate cancer. However, few have reported outcomes for prostate SBRT using periprostatic hydrogel spacer (SpaceOAR; Augmenix). Herein, we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Hwang, Mark E., Mayeda, Mark, Liz, Maria, Goode-Marshall, Brenda, Gonzalez, Lissette, Elliston, Carl D., Spina, Catherine S., Padilla, Oscar A., Wenske, Sven, Deutsch, Israel
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6679492/
https://ncbi.nlm.nih.gov/pubmed/31375119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1346-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados